A US courtroom upheld the convictions of Theranos’ founder Elizabeth Holmes and President Ramesh “Sunny” Balwani on Monday, on prices of defrauding buyers within the failed blood testing startup as soon as valued at $9 billion.
A 3-judge panel for the ninth US Circuit Courtroom of Appeals in San Francisco rejected claims of authorized errors at their separate trials held in 2022.
Holmes, who began Theranos as a school scholar and have become its public face, was indicted alongside Balwani, her former romantic companion, in 2018. The 2 had been sentenced in 2022 to 11 years and three months, and 12 years and 11 months, respectively.
